EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TCN1 Drives Malignant Progression of Pancreatic Cancer Through STAT4-Mediated Transcriptional Activation of the DUOX2/ROS Signaling Axis

Zonglin Liu, Dongxue Ju, Ze Yu, Binru Zhang, Dongbo Xue iD, Yongwei Wang

Cancers · 12.10.2025 · 17 (20) · 3300

DOI: 10.3390/cancers17203300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 12.10.2025. Verfasst von Zonglin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbi…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Scientific Foundation of China, Distinguished Young Investigator Fund of the First Affiliated Hospital of Harbin Medical University, Innovative Young Talents Training Scheme for general undergraduate higher education institutions in Heilongjiang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) is characterized by its aggressive clinical behavior and intricate microenvironment regulation, leading to dismal prognosis. Elucidating the molecular mechanisms underlying PDAC pathogenesis is crucial for developing improved therapeutic approaches. The functional significance and molecular basis of transcobalamin 1 (TCN1) in PDAC remain largely unexplored. Methods and Results: Through integrated analysis of TCGA and GTEx datasets combined with 80 clinical specimens, we identified significant TCN1 overexpression in PDAC, showing a positive association with tumor stage and negative associations with histological differentiation and overall survival. Functional investigations showed that TCN1 enhanced pancreatic cancer cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) in both in vitro and in vivo models. Mechanistically, TCN1 physically interacts with signal transducer and activator of transcription 4 (STAT4) to enhance its transcriptional activity. Chromatin immunoprecipitation (ChIP) assays showed that STAT4-mediated transcriptional activation of dual oxidase 2 (DUOX2) occurs through direct promoter binding. As a pivotal reactive oxygen species (ROS)-generating enzyme, DUOX2 overexpression elevates intracellular ROS levels, thereby promoting EMT progression and activating proliferation-related signaling cascades. Antioxidant treatment effectively abrogated TCN1-driven oncogenic phenotypes, establishing ROS as the critical downstream mediator.

Conclusions

Collectively, our findings reveal a novel TCN1/STAT4/DUOX2 regulatory axis that exacerbates PDAC progression by remodeling redox homeostasis. This signaling cascade may serve as a prognostic biomarker and a potential therapeutic target for ROS-directed precision therapy in PDAC.

Schlagwörter

Stichwörter der Autor:innen

PDACSTAT4TCN1pancreatic cancersignaling axis

Autor:innen und Institutionen

  • Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China.
  • Key Laboratory of Hepatosplenic Surgery, Ministry of Education, 23 Youzheng Street, Nangang District, Harbin 150001, China.

ORCID-Profile: Dongbo Xue

Förderung

  • National Nature Scientific Foundation of China
  • Distinguished Young Investigator Fund of the First Affiliated Hospital of Harbin Medical University
  • Innovative Young Talents Training Scheme for general undergraduate higher education institutions in Heilongjiang
  • Heilongjiang postdoctoral scientific research developmental fund

Zitieren

APA

Liu, Z., Ju, D., Yu, Z., Zhang, B., Xue, D., & Wang, Y. (2025). TCN1 Drives Malignant Progression of Pancreatic Cancer Through STAT4-Mediated Transcriptional Activation of the DUOX2/ROS Signaling Axis. Cancers, 17(20), 3300. https://doi.org/10.3390/cancers17203300

Vancouver

Liu Z, Ju D, Yu Z, Zhang B, Xue D, Wang Y. TCN1 Drives Malignant Progression of Pancreatic Cancer Through STAT4-Mediated Transcriptional Activation of the DUOX2/ROS Signaling Axis. Cancers. 2025;17(20):3300. doi:10.3390/cancers17203300

BibTeX
@article{Liu2025,
  author = {Liu, Zonglin and Ju, Dongxue and Yu, Ze and Zhang, Binru and Xue, Dongbo and Wang, Yongwei},
  title = {TCN1 Drives Malignant Progression of Pancreatic Cancer Through STAT4-Mediated Transcriptional Activation of the DUOX2/ROS Signaling Axis},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {20},
  pages = {3300},
  doi = {10.3390/cancers17203300}
}
Kostenlos starten →